Contrast/noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas

被引:41
作者
Fayed, Nicolas
Morales, Humberto
Modrego, Pedro J.
Pina, Miguel A.
机构
[1] Miguel Servet Univ Hosp, Magnet Resonance Unit, Clin Quiron, Zaragoza, Spain
[2] Miguel Servet Univ Hosp, Dept Neurol, Zaragoza, Spain
关键词
brain tumors; conventional magnetic resonance imaging; magnetic resonance spectroscopy; contrast-to-noise ratio;
D O I
10.1016/j.acra.2006.01.047
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives. Histopathology is the gold standard to establish the grade of brain tumors but biopsy and/or surgery are not always possible. The aim of this study is to determine whether histological grade of tumors may be predicted by means of conventional gadolinium-enhanced MRI and proton magnetic resonance spectroscopy (MRS). Materials and Methods. In this study, we included 35 consecutive patients with single brain tumors and final histopathological verification: 12 had low-grade glioma, 16 had high-grade glioma, and 7 had single metastasis. Initially, we carried out TI and T2 MRI paying attention to the following features: border definition, mass effect, heterogeneity of signal, perilesional edeme, hemorrhage, necrosis, and corpus callosum invasion. Gadolinium-enhancement was evaluated with the contrast-to-noise ratio (CNR). Next, single-voxel proton MRS was carried out to measure the absolute values of metabolites (N-acetyl-aspartate, creatine, choline, and myo-inositol) and their ratios in the area of maximum contrast enhancement. Results. We found that gadolinium-enhancement measured with the CNR (CNR > 35.86) predicted malignancy at 82.6% sensitivity and 91.7% specificity (area under the curve, 0.88; 95% confidence interval [CI], 0.73-0.97). With regard to MRS a choline/creatine ratio higher than 1.56 predicted malignancy at 88.9% sensitivity and 91.7% specificity (area under the curve, 0.94; 95% CI, 0.78-0.99). When we combined the CNR value, the choline/creatine ratio, and the presence of lactates in a model of discriminant analysis the predictive power improved significantly with an area under the curve of 0.99% (95% CI, 0.87-1). However, the used techniques were unable to distinguish metastases from high-grade gliomas accurately. Conclusions. The intensity of contrast enhancement measured with the CNR, the choline/creatine ratio, and the presence of lactate were the most powerful variables to predict malignancy in brain tumors. The CNR is a simple, objective, and useful tool in the initial assessment of gliomas and metastases.
引用
收藏
页码:728 / 737
页数:10
相关论文
共 50 条
  • [1] [Anonymous], 2003, Neuroradiology: The Requisites
  • [2] GD-DTPA IN CLINICAL MR OF THE BRAIN .1. INTRAAXIAL LESIONS
    BRANTZAWADZKI, M
    BERRY, I
    OSAKI, L
    BRASCH, R
    MUROVIC, J
    NORMAN, D
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1986, 147 (06) : 1223 - 1230
  • [3] NONINVASIVE DIFFERENTIATION OF TUMORS WITH USE OF LOCALIZED H-1 MR SPECTROSCOPY INVIVO - INITIAL EXPERIENCE IN PATIENTS WITH CEREBRAL-TUMORS
    BRUHN, H
    FRAHM, J
    GYNGELL, ML
    MERBOLDT, KD
    HANICKE, W
    SAUTER, R
    HAMBURGER, C
    [J]. RADIOLOGY, 1989, 172 (02) : 541 - 548
  • [4] Castillo M, 2000, AM J NEURORADIOL, V21, P1645
  • [5] Castillo M, 1996, AM J NEURORADIOL, V17, P1
  • [6] Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children
    Colosimo, C
    Demaerel, P
    Tortori-Donati, P
    Christophe, C
    Van Buchem, M
    Högström, B
    Pirovano, G
    Shen, N
    Kirchin, M
    Spinazzi, A
    [J]. PEDIATRIC RADIOLOGY, 2005, 35 (05) : 501 - 510
  • [7] GLIOMAS - CLASSIFICATION WITH MR IMAGING
    DEAN, BL
    DRAYER, BP
    BIRD, CR
    FLOM, RA
    HODAK, JA
    COONS, SW
    CAREY, RG
    [J]. RADIOLOGY, 1990, 174 (02) : 411 - 415
  • [8] The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification
    Devos, A
    Simonetti, AW
    van der Graaf, M
    Lukas, L
    Suykens, JAK
    Vanhamme, L
    Buydens, LMC
    Heerschap, A
    Van Huffel, S
    [J]. JOURNAL OF MAGNETIC RESONANCE, 2005, 173 (02) : 218 - 228
  • [9] DOWNLING C, 2001, AM J NEURORADIOL, V22, P604
  • [10] In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases
    Fan, G
    Sun, B
    Wu, Z
    Guo, Q
    Guo,Y
    [J]. CLINICAL RADIOLOGY, 2004, 59 (01) : 77 - 85